Webb9 jan. 2024 · In this piece, I explain why legislation addressing product hopping is the best option to address this anticompetitive behavior. I focus on the Affordable Prescriptions for Patients Act of 2024, bipartisan legislation that addresses the harms from product hopping while appropriately deferring to any reasonable justifications the drug company could … Webb31 mars 2024 · Product hopping—in which a drug company strategically shifts the market from one drug product to another right before generic competition can occur—costs …
Product Hopping—An Expensive and Wasteful Practice - JAMA
Webb1 okt. 2015 · The Federal Trade Commission filed an amicus brief before the U.S. Court of Appeals for the Third Circuit explaining that the district court made significant analytical errors in ruling for defendants in a dispute involving allegations of pharmaceutical “product hopping.” The brief explains that, in examining whether such conduct is unlawful, courts … WebbProduct hopping is an ine cient way to provide ex ante innovation incentives. An e cient mechanism would ban product (requires regulation) and also provide ex ante incentives … is aphrodite still alive in god of war
TH ST CONGRESS SESSION H. R. 2873
Webb19 jan. 2024 · Iyengar, “Should Pharmaceutical Product Hopping Be Subject to Antitrust Scrutiny,” Journal of the Patent and Trademark Office Society 97, no. 4 (2015): 663-689. … Webb9 jan. 2024 · In this piece, I explain why legislation addressing product hopping is the best option to address this anticompetitive behavior. I focus on the Affordable Prescriptions … WebbProduct Hopping and Innovation Incentives∗ JorgeLemus†andOlguOzkul‡ March26,2024 Abstract Weexploreinnovationincentivesinthepresenceof“producthopping ... omani health center